Offering early access to the new diagnostic paradigm, pilot partnerships with selected institutions engaged by year-end
Elecsys pTau181 is the first in vitro diagnostic regulation (IVDR)-certified test to rule out Alzheimer’s associated amyloid pathology
Designed for use in decentralized, CLIA-waived settings, the test has been analytically verified in a study to deliver results comparable to standard laboratory methods
Discover Biacore™ SPR systems, a flexible offering for real-time label-free interaction analysis
Brain-targeted gene editing improved symptoms and survival rates in mice with the genetic mutations behind alternating hemiplegia of childhood
Crown Bioscience to deliver clinical-grade testing, further strengthening its support for clients' clinical and translational drug development efforts
This collaboration is working to accelerate development of next-generation basophil activation testing
Advancing clinical pharmacokinetic prediction beyond non-human primate models
